Induced sputum in patients with interstitial lung disease: a non-invasive surrogate for certain parameters in

M Sobiecka1, J Kus, U Demkow

  • 1First Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland. m.sobiecka@openstar.pl.

Insights

Induced sputum is a viable non-invasive alternative to bronchoalveolar lavage fluid (BALF) for assessing interstitial lung disease. Cellular composition and T-lymphocyte correlations suggest induced sputum can substitute for BALF in specific patient parameters.

Area of Science:

  • Pulmonology
  • Immunology
  • Cellular Biology

Background:

  • Induced sputum offers a non-invasive method for evaluating airway and parenchymal lung diseases.
  • Interstitial lung diseases (ILDs) require accurate diagnostic methods for cellular and immunological assessment.
  • Bronchoalveolar lavage fluid (BALF) analysis is invasive but provides detailed cellular information.

Purpose of the Study:

  • To compare the cellular composition and T-lymphocyte subpopulations between induced sputum and BALF in patients with ILD.
  • To determine if induced sputum can serve as a non-invasive surrogate for BALF analysis in ILD.
  • To investigate differences in cellular profiles between induced sputum and BALF in specific ILDs.

Main Methods:

  • Evaluated 33 patients diagnosed with interstitial lung disease (sarcoidosis, hypersensitivity pneumonitis, idiopathic pulmonary fibrosis).
  • Compared cellular composition (macrophages, neutrophils) and T-lymphocyte subsets (CD4+, CD8+, CD4+/CD8+ ratio) in induced sputum and BALF.
  • Utilized statistical analysis to assess correlations and significant differences between the two sample types.

Main Results:

  • Macrophages were significantly lower in induced sputum than BALF in sarcoidosis (P=0.005).
  • Neutrophils were significantly higher in induced sputum than BALF in sarcoidosis (P=0.001) and hypersensitivity pneumonitis (P=0.006).
  • Strong correlations were observed between BALF and induced sputum for CD4+, CD8+ subsets, and the CD4+/CD8+ ratio across all patients and subgroups (P<0.001).

Conclusions:

  • Induced sputum demonstrates a strong correlation with BALF for T-lymphocyte subsets in patients with interstitial lung disease.
  • Induced sputum may serve as a non-invasive surrogate for certain BALF parameters in the assessment of ILDs.
  • The findings support the utility of induced sputum as a less invasive diagnostic tool for ILD.